Category: Uncategorized
GE Healthcare and Wayra select five AI-led healthtech start-ups for first Edison™ Accelerator
The ‘Edison Accelerator’ provides world-class clinical, technical and commercial mentorship to EMEA-based start-ups London, UK – 24 June 2021 – Five healthtech start-ups have officially become the first cohort of the Edison Accelerator in EMEA – a healthcare start-up and scale-up acceleration programme designed by GE Healthcare in partnership with innovation organisation Wayra UK. The... Read more
GE Healthcare and Wayra select six AI-led healthtech start-ups for EMEA Edison™ Accelerator
The ‘Edison Accelerator’ provides world-class clinical, technical and commercial mentorship to EMEA-based start-ups London, UK – 24 June 2021 – Six healthtech start-ups have officially become the first cohort of the Edison Accelerator in EMEA – a healthcare start-up and scale-up acceleration programme designed by GE Healthcare in partnership with innovation organisation Wayra UK. The... Read more
MKS Instruments Celebrates 60th Anniversary of the Founding of the Company
ANDOVER, Mass., June 15, 2021 (GLOBE NEWSWIRE) — MKS Instruments, Inc . (NASDAQ: MKSI “MKS”), a global provider of technologies that enable advanced processes and improve productivity, today announced that it is celebrating the 60 th anniversary of the founding of the company. John T.C. Read more
Roche data at EAN 2021 showcase significant impact of therapies across diverse neuroscience portfolio
Data for EVRYSDI reinforce safety profile and efficacy in a broad spinal muscular atrophy (SMA) population, following recent EU approval Data for ENSPRYNG in neuromyelitis optica spectrum disorder (NMOSD) build on safety profile and efficacy following recent CHMP opinion, including in adults with concomitant autoimmune diseases (CAIDs) OCREVUS data continue to show consistent benefit on... Read more
Roche obtains CE mark for the SARS-CoV-2 Antigen Self Test Nasal allowing for rapid self testing of COVID-19 at home
The SARS-CoV-2 Antigen Self Test Nasal enables individuals to quickly and conveniently test themselves for COVID-19 at home using a simple nasal swab An early version of the test has already been available as a home-test in a number of European markets under local special approval pathways since February 2021 The test will be widely... Read more
24 Hours of Life Science Conference
On June 2, 2021, JEOL will focus on advances in life science research using electron microscopy in its “24 Hours of Life Science” conference. Twenty-four different sessions throughout the full day will cover topics including: – Connectomics and the study of complete volumes of tissues or materials captured at high resolution– Correlative microscopy using light... Read more
MKS Instruments Increases Quarterly Cash Dividend
ANDOVER, Mass., May 12, 2021 (GLOBE NEWSWIRE) — MKS Instruments, Inc. (NASDAQ: MKSI), a global provider of technologies that enable advanced processes and improve productivity, today announced that its Board of Directors has authorized a quarterly cash dividend of $0.22 per share, a ten percent Read more
GE Healthcare Acquires Zionexa; Molecular Imaging Agent Aims to Enable More Targeted Treatment for Metastatic Breast Cancer Patients
GE Healthcare to scale Zionexa’s FDA-approved PET imaging agent, Cerianna (fluoroestradiol F-18), used as an adjunct to biopsy for the detection of estrogen receptor (ER) positive lesions to help inform treatment selection for patients with recurrent or metastatic breast cancer Aims to make Cerianna available to 75% of metastatic breast cancer patients in the U.S.... Read more
Roche’s Tecentriq approved by European Commission as a first-line monotherapy treatment for people with a type of metastatic non-small cell lung cancer
Tecentriq significantly improved overall survival in people with high PD-L1 expression, compared with chemotherapy in a Phase III study Tecentriq approval offers an alternative to chemotherapy for all eligible patients This approval marks Tecentriq’s fourth indication in metastatic non-small cell lung cancer and fifth indication in lung cancer overall in the EU Basel, 5 May... Read more